Antioxidants to prevent Alzheimer's disease

Antioxidants to prevent Alzheimer's disease
INRS Professor Charles Ramassamy, specialist on Alzheimer's disease, doctoral student Mohamed Raâfet Ben Khedher and postdoctoral student Mohamed Haddad. Credit: INRS

Research conducted by Ph.D student Mohamed Raâfet Ben Khedher and postdoctoral researcher Mohamed Haddad of the Institut national de la recherche scientifique (INRS) has shown that an oxidation-antioxidant imbalance in the blood is an early indicator of Alzheimer's disease, rather than a consequence. This breakthrough made by researchers under the supervision of the Professor Charles Ramassamy provides an avenue for preventive intervention: the antioxidants intake.

The research team showed that oxidative markers, known to be involved in Alzheimer's , show an increase up to five years before the onset of the disease. The results of this study, published in the Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) journal, suggest that oxidation may be an early marker of this disease that affects more than 500,000 Canadians.

"Given that there is an increase in in people who develop the disease, we may regulate the antioxidant systems. For example, we could modulate the antioxidant systems, such as apolipoproteins J and D, which transport lipids and cholesterol in the blood and play an important role in brain function and Alzheimer's disease. Another avenue would be to increase the intake of antioxidants through nutrition," says Professor Ramassamy.

Accessible biomarkers

Unlike the current set of invasive and expensive tests used to diagnose Alzheimer's disease, the oxidative markers discovered by Professor Ramassamy's research team can be detected by a blood test. These markers are found in plasma extracellular vesicles, which are pockets released by all cells in the body, including those in the brain.

Antioxidants to prevent Alzheimer's disease
Credit: Institut national de la recherche scientifique - INRS

The research team focused specifically on the "sporadic" Alzheimer's disease, the most common form of the disease which results primarily from the presence of the APOE4 susceptibility gene. This same form of the disease had been studied by the team for other early markers.

"By identifying oxidative markers in the blood of individuals at risk five years before the onset of the disease, we could make recommendations to slow the onset of the disease and limit the risks," scientists noted.

This breakthrough brings new hope to Alzheimer's research. Once the disease is symptomatic, it is difficult, if not impossible, to reverse it.

The article, "Effect of APOE ε4 allele on levels of apolipoproteins E, J, and D, and redox signature in circulating extracellular vesicles from cognitively impaired with no dementia participants converted to Alzheimer's disease", was published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.


Explore further

Discovery of early plasma biomarkers for Alzheimer's disease

More information: Mohamed Raâfet Ben Khedher et al, Effect of APOE ε4 allele on levels of apolipoproteins E, J, and D, and redox signature in circulating extracellular vesicles from cognitively impaired with no dementia participants converted to Alzheimer's disease, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (2021). DOI: 10.1002/dad2.12231
Provided by Institut national de la recherche scientifique - INRS
Citation: Antioxidants to prevent Alzheimer's disease (2021, October 12) retrieved 24 October 2021 from https://medicalxpress.com/news/2021-10-antioxidants-alzheimer-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
126 shares

Feedback to editors